167 related articles for article (PubMed ID: 37664238)
1. Comparison of viscous budesonide and fluticasone in the treatment of patients with eosinophilic esophagitis: a systematic review and meta-analysis.
Numan L; Kalot MA; Brotherton T; Tarakji A; Hamdeh S
Ann Gastroenterol; 2023; 36(5):511-516. PubMed ID: 37664238
[TBL] [Abstract][Full Text] [Related]
2. Topical steroids in eosinophilic esophagitis: Systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Murali AR; Gupta A; Attar BM; Ravi V; Koduru P
J Gastroenterol Hepatol; 2016 Jun; 31(6):1111-9. PubMed ID: 26699695
[TBL] [Abstract][Full Text] [Related]
3. Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.
Albert D; Heifert TA; Min SB; Maydonovitch CL; Baker TP; Chen YJ; Moawad FJ
Dig Dis Sci; 2016 Jul; 61(7):1996-2001. PubMed ID: 27093866
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Pharmacologic Therapy for Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis.
Tomizawa Y; Melek J; Komaki Y; Kavitt RT; Sakuraba A
J Clin Gastroenterol; 2018 Aug; 52(7):596-606. PubMed ID: 28787360
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
[TBL] [Abstract][Full Text] [Related]
6. Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis.
Fable JM; Fernandez M; Goodine S; Lerer T; Sayej WN
J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):26-32. PubMed ID: 28489670
[TBL] [Abstract][Full Text] [Related]
7. Histologic and Clinical Effects of Different Topical Corticosteroids for Eosinophilic Esophagitis: Lessons from an Updated Meta-Analysis of Placebo-Controlled Randomized Trials.
de Heer J; Miehlke S; Rösch T; Morgner A; Werner Y; Ehlken H; Becher H; Aigner A
Digestion; 2021; 102(3):377-385. PubMed ID: 32610332
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.
Lasserson TJ; Ferrara G; Casali L
Cochrane Database Syst Rev; 2011 Dec; (12):CD004106. PubMed ID: 22161385
[TBL] [Abstract][Full Text] [Related]
10. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
O'Shea O; Stovold E; Cates CJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162
[TBL] [Abstract][Full Text] [Related]
11. Systematic review with network meta-analysis: comparative effectiveness of topical steroids vs. PPIs for the treatment of the spectrum of eosinophilic oesophagitis.
Lipka S; Kumar A; Miladinovic B; Richter JE
Aliment Pharmacol Ther; 2016 Mar; 43(6):663-73. PubMed ID: 26834077
[TBL] [Abstract][Full Text] [Related]
12. A Network Meta-Analysis of Randomized Controlled Trials on the Treatment of Eosinophilic Esophagitis in Adults and Children.
Rokkas T; Niv Y; Malfertheiner P
J Clin Gastroenterol; 2021 May-Jun 01; 55(5):400-410. PubMed ID: 32398629
[TBL] [Abstract][Full Text] [Related]
13. Histological Outcomes of Pharmacological Interventions in Eosinophilic Esophagitis for Adults and Children: A Network Meta-analysis of Randomized Controlled Trials.
Aziz M; Haghbin H; Gangwani MK; Fatima R; Sohail AH; Ali H; Alyousif ZA; Dahiya DS; Lee-Smith W; Beran A; Kamal F; Nawras A
J Clin Gastroenterol; 2024 May; ():. PubMed ID: 38701235
[TBL] [Abstract][Full Text] [Related]
14. Six-Food Elimination Diet and Topical Steroids are Effective for Eosinophilic Esophagitis: A Meta-Regression.
Cotton CC; Eluri S; Wolf WA; Dellon ES
Dig Dis Sci; 2017 Sep; 62(9):2408-2420. PubMed ID: 28608048
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis on randomized controlled trials of treating eosinophilic esophagitis with budesonide.
Liu X; Xiao X; Liu D; Tan C
Ann Med; 2022 Dec; 54(1):2078-2088. PubMed ID: 35862288
[TBL] [Abstract][Full Text] [Related]
16. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
Munoz-Persy M; Lucendo AJ
Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
[TBL] [Abstract][Full Text] [Related]
17. Recent insights on the use of topical steroids in eosinophilic esophagitis.
Reddy A; Ashat D; Murali AR
Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):953-963. PubMed ID: 32567417
[TBL] [Abstract][Full Text] [Related]
18. Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth.
Axelsson I; Naumburg E; Prietsch SO; Zhang L
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD010126. PubMed ID: 31194879
[TBL] [Abstract][Full Text] [Related]
19. Strategies for Medical Management of Pediatric Eosinophilic Esophagitis.
Chawla N; Deshmukh M; Sharma A; Patole S
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):e152-e157. PubMed ID: 27306106
[TBL] [Abstract][Full Text] [Related]
20. A New Viscous Budesonide Formulation for the Treatment of Eosinophilic Esophagitis in Children: A Preliminary Experience and Review of the Literature.
Warzecha J; Dziekiewicz M; Bieńkowska-Tokarczyk A; Małecki M; Banaszkiewicz A
J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
